ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 214 filers reported holding ROYALTY PHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $228,671,218 | -9.1% | 8,425,616 | +2.9% | 0.01% | 0.0% |
Q2 2023 | $251,663,400 | -16.3% | 8,186,838 | -1.8% | 0.01% | -23.5% |
Q1 2023 | $300,519,204 | -53.2% | 8,340,805 | -48.6% | 0.02% | -10.5% |
Q4 2022 | $641,795,474 | +101.6% | 16,239,764 | +105.0% | 0.02% | -5.0% |
Q3 2022 | $318,282,000 | -1.0% | 7,921,415 | +3.6% | 0.02% | +5.3% |
Q2 2022 | $321,385,000 | +6.3% | 7,644,740 | -1.5% | 0.02% | +26.7% |
Q1 2022 | $302,430,000 | +7.2% | 7,762,572 | +9.7% | 0.02% | +15.4% |
Q4 2021 | $282,032,000 | +33.7% | 7,077,330 | +21.3% | 0.01% | +18.2% |
Q3 2021 | $210,868,000 | +5.7% | 5,834,745 | +19.9% | 0.01% | 0.0% |
Q2 2021 | $199,524,000 | -2.4% | 4,867,634 | +3.9% | 0.01% | -8.3% |
Q1 2021 | $204,397,000 | +73.2% | 4,685,863 | +98.7% | 0.01% | +71.4% |
Q4 2020 | $118,005,000 | +175.5% | 2,357,742 | +131.6% | 0.01% | +133.3% |
Q3 2020 | $42,835,000 | +2062.3% | 1,018,194 | +2395.6% | 0.00% | – |
Q2 2020 | $1,981,000 | – | 40,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |